Nature Reviews Immunology Submission Guide

Source: Clarivate JCR 2024, Nature Reviews Immunology editorial disclosures (accessed April 2026).

Submission caps: NRI operates a pre-submission inquiry model with a 1-2 page proposal. Invited Reviews cap at 5000 to 7000 words main text with up to 6 figures or boxes and 100 to 150 references; Perspectives cap at 3000 to 4000 words. Comment articles run about 1000 words. Supplementary information files commonly accept up to 100 MB per upload.

• Day 0: Nature manuscript tracking submission. The Nature Portfolio journal page portal accepts the proposal (one-page inquiry, scope outline, timing argument, key references, ORCID identifiers, candidate author affiliations, conflicts of interest, funding statement), runs Nature Portfolio integrity checks, and routes to a handling NRI editor matching the immunology subfield.

• Days 1 to 21: Pre-submission editor read. The editor evaluates topic timing relative to NRI / Annual Review of Immunology / Trends in Immunology coverage in the last 24 months, broad-immunology readership fit, and author primary-research standing within the last 5 years.

• Days 21 to 90: Invited writing. For inquiries that pass, the author team is invited to submit a full manuscript. Reviews take 3 to 6 months to draft.

• Days 90 to 180: External peer review. Two or three reviewers spanning the immunology subspecialty. Reviewer reports return on a 6 to 12 week cadence.

• Days 180 to 270: Revision rounds and publication. Nature Portfolio production typically pushes accepted Reviews online within 4 to 6 weeks of acceptance.

Source: Nature Reviews Immunology author guidelines, Springer Nature.

Use this page when you are still deciding:

• whether the topic has timing and novelty headroom relative to recent reviews

• whether the scope is broad enough for a broad immunology readership

• whether the author team's standing supports a Nature Reviews piece

• what the inquiry letter must accomplish

Before submitting a pre-submission inquiry, the proposal should make four things clear in one page:

• the specific topic or argument the synthesis will advance

• why the synthesis is needed now (recent immunology paradigm shift, technological inflection, public-health moment)

• what differentiates the proposal from existing reviews on adjacent topics

• why this author team is positioned to write the definitive synthesis

At minimum, the inquiry includes:

• a working title that states the synthesis

• a 200-300 word scope outline

• a "why now" paragraph naming recent immunology developments

• a paragraph distinguishing from existing reviews

• a candidate author list with primary-research credentials

• a proposed length and figure structure

Common failures here are timing and authority failures:

• The proposed topic was reviewed within 24 months. Editors check existing literature before responding.

• The "why now" case is generic. "Recent advances in [immunology topic]" is not a why-now case. Editors look for a specific inflection.

• The angle is not differentiated. A proposal structurally indistinguishable from a recent review even if the topic is technically new.

• The author team lacks primary-research depth. If no proposed author has published primary research in the proposed topic within 5 years, the proposal is typically returned.

NRI is a venue for definitive immunology syntheses, not surveys or original research findings.

The commissioning model: roughly 70-80% of published pieces start with a Nature Reviews editor approaching a researcher. Pre-submission inquiries compete against pieces editors are already developing.

The 24-month timing window: NRI rarely commissions a comprehensive review of a topic covered in NRI, Annual Review of Immunology, Immunity Reviews, or Trends in Immunology within the last 24 months.

The breadth standard: the journal serves immunologists across innate, adaptive, cellular, infection, tumor, autoimmunity, and vaccine immunology. A Review useful only to a single sub-discipline is usually redirected.

The proposal needs:

• a synthesis-level argument with cross-subfield implications

• one defensible "why now" inflection point

• author credentials signaling authority on the specific topic

• a clear point of view, not a neutral summary

Before submitting to Nature Reviews Immunology, a Nature Reviews Immunology submission readiness check identifies whether the package meets the editorial bar before you commit to the submission.

The strongest NRI inquiries sound like one editor briefing another on a piece worth commissioning.

They usually:

• state the central argument in one sentence

• explain why the synthesis is needed in this 18-month window

• distinguish from 2-3 existing reviews

• establish author credentials in 2-3 sentences

• propose a working title and section outline

Editors first check whether the inquiry deserves to be commissioned now: the topic timing, the distinct synthesis angle, and the author team's authority. The outline should make those signals obvious before the editor reaches the detailed topic map or candidate figure plan.

• Is Nature Reviews Immunology a good journal?

• Nature Reviews Immunology journal overview

• Nature Reviews Microbiology submission guide

Before drafting the inquiry, run your proposal through a Nature Reviews Immunology pre-submission readiness check.

For a broader file-level scan before upload, use the Manusights AI manuscript review to catch readiness gaps across framing, methods, and journal fit.

Across Manusights submission reviews for immunology review proposals targeting Nature Reviews Immunology, three patterns generate the most consistent inquiry-stage rejections. (Per Nature Reviews Immunology author guidance, proposals should be submitted as a synopsis with a 200-word abstract, main-section outline, key references, and author affiliations;

the journal considers Review-type and Comment-type proposals and does not publish original research, case studies, meta-analyses, or systematic reviews.) These patterns are testable in the proposal abstract, section outline, reference map, author list, figure plan, and cover letter before you contact the Nature Reviews Immunology editors.

Original-research or systematic-review logic disguised as a Nature Reviews proposal

Across Nature Reviews Immunology-targeted manuscripts, the clearest immediate rejection pattern is a proposal whose internal logic still belongs to a primary research article, meta-analysis, systematic review, or case-based clinical paper. Nature Reviews Immunology explicitly says it does not publish original research, case studies, meta-analyses, or systematic reviews.

Editors can see the mismatch in the abstract, methods language, section outline, figure plan, and reference map. Warning signs include a proposal organized around a dataset, cohort, trial subgroup, or PRISMA-style search strategy; a methods section that promises new analysis rather than synthesis; figures that display new results instead of conceptual organization; and a cover letter emphasizing novelty of data rather than novelty of interpretation.

These proposals usually route better to Nature Immunology for primary immunology research, Immunity for mechanistic cellular and molecular immunology, The Journal of Experimental Medicine for disease-mechanism studies, Clinical Immunology for translational clinical papers, Frontiers in Immunology for broader review and mini-review formats, or a systematic-review venue when the method is evidence synthesis rather than invited narrative analysis.

The fix is to remove the primary-data promise, rebuild the synopsis around a field-level argument, make the 200-word abstract state the conceptual shift, and use figures or boxes to organize mechanisms, debates, or practice implications rather than report original findings.

Check whether your NRI inquiry is a synthesis rather than a disguised original study →

Review topic collides with recent NRI, Annual Review, Trends, or Immunity coverage

In Manusights reviews, the second recurring pattern is timing collision. The proposed Nature Reviews Immunology topic may be important, but a recent comprehensive review has already occupied the synthesis slot. Editors check this quickly through the key-reference list, outline, and "why now" paragraph.

A weak proposal lists recent NRI, Annual Review of Immunology, Trends in Immunology, Immunity, Cell Host & Microbe, or Nature Reviews Disease Primers articles without explaining how the new manuscript changes the frame.

The manuscript components that reveal the problem are a generic "recent advances" title, section headings that mirror a recent review, figures that repeat the same mechanism map, and a cover letter that says the field is fast-moving without naming the specific inflection.

A publishable Nature Reviews Immunology synopsis needs a reason to exist now: a post-trial consensus change, a new immunotherapy class, a revised model of innate-adaptive crosstalk, a vaccine-platform inflection, a disease-area reclassification, or a technology that changes what can be measured.

If no distinct timing case exists, route to Trends in Immunology for a focused opinion, Current Opinion in Immunology for narrower update pieces, Annual Review for annual synthesis, Immunity Reviews for cellular and molecular emphasis, or a specialist review venue where overlap is less fatal.

Check whether your NRI inquiry has timing headroom against recent reviews →

Author team and figure architecture do not prove broad immunology authority

Across Manusights submission reviews for NRI inquiries, the third pattern is a proposal with a plausible topic but an author team or visual plan that does not support a Nature Reviews-level synthesis. Nature Reviews Immunology is read across innate, adaptive, cellular, infection, tumor, autoimmunity, vaccine, and systems immunology audiences. The proposal must show that the authors can synthesize across those boundaries.

Editors can see weakness in the author affiliations, publication record, section assignments, figure captions, and reference balance. Warning signs include one senior author with authority in a narrow subfield but no co-author covering adjacent mechanisms, a reference map dominated by the authors' own papers, figure plans that summarize pathways without comparing competing models, and an outline that serves only one immunology subcommunity.

Stronger inquiries usually assign authors to complementary expertise areas, propose figures that teach mechanism and decision logic, and make the cover letter explain why this team can write the synthesis now. If the team cannot demonstrate that breadth, the better route is a focused Review or Perspective at Trends in Immunology, Mucosal Immunology, Cellular & Molecular Immunology, Frontiers in Immunology, or a disease-area review journal.

The fix is to reshape the author list and figure architecture before submitting, not after an editor asks for a broader angle.

Check whether your Nature Reviews Immunology inquiry is submission-ready →

How do I submit to Nature Reviews Immunology?

Nature Reviews Immunology is primarily commissioned. The standard path is a pre-submission inquiry to the editorial team containing a one-page outline (proposed scope, why now, what's new, candidate authors). If editors are interested, they invite a full submission. Unsolicited full manuscripts are typically returned with a request to submit an inquiry first.

What does Nature Reviews Immunology publish?

Reviews (5,000-7,000 words synthesizing an immunology subfield), Perspectives (3,000-4,000 words advancing a viewpoint), Comment (~1,000-word opinion), and Research Highlights (short editor-written summaries). Original research is not published. The journal serves immunologists who want a synthesis from leading authorities.

Why does Nature Reviews Immunology reject most pre-submission inquiries?

Most rejections involve scope too narrow for a broad immunology readership, timing collisions with recent NRI, Annual Review of Immunology, or Trends in Immunology pieces, undifferentiated angle, or author teams without sustained primary-research records in the proposed area.

Do I need to be a senior PI to publish in Nature Reviews Immunology?

Effectively yes. The journal commissions reviews from researchers with established immunology field reputations. Junior researchers are sometimes co-authors with senior PIs, but proposals from groups without senior immunology track records are rarely accepted.